Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
about
Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic ReviewImpact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.Testing previous model predictions against new data on human papillomavirus vaccination program outcomes.The potential impact of HPV-16 reactivation on prevalence in older Australians.Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program.Human papilloma virus vaccination: impact and recommendations across the world.Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from AustraliaMeasuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)Towards the eradication of HPV infection through universal specific vaccination.Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational studyImmunoprevention of human papillomavirus-associated malignanciesParents' views on human papillomavirus vaccination for sexually transmissible infection prevention: a qualitative studyAssociations Between Exposure to and Expression of Negative Opinions About Human Papillomavirus Vaccines on Social Media: An Observational StudyParents' Recall and Reflections on Experiences Related to HPV Vaccination for Their Children.Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, AustraliaModeling preventative strategies against human papillomavirus-related disease in developed countriesTen years of anti-HPV vaccinations: what do we know?Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia.Australia's contribution to global immunisation.Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer.Human papillomavirus vaccination: where are we now?Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.Measuring HPV vaccination coverage in Australia: comparing two alternative population-based denominators.The effect of making a 'third dose assumption' on HPV coverage estimates.Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.Barriers to better three-dose coverage with HPV vaccination in school-based programs.Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk?Aggregation and competitive exclusion: explaining the coexistence of human Papillomavirus types and the effectiveness of limited vaccine conferred cross-immunity.Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention.Ethical Challenges in School-Based Immunization Programs for Adolescents: A Qualitative Study
P2860
Q28262413-15C073F9-8183-4A74-9A7E-267CA9038AE9Q30682187-2F2C1560-9FB2-4A3C-BC62-A34147D86AB7Q30764433-CE3FFCFC-3239-438E-AEBE-A51214F6A804Q33769284-82B13C4F-A0D8-4A8E-8CDA-8AEAF74FBA8BQ34626578-1A1F82FB-B134-4097-B48F-AF21BBB911A2Q34704575-36884651-FC9B-4EF5-9150-F1BBFB5491C1Q34731097-030E11E5-9333-40F6-AD15-904ECEA6427EQ34777452-D5D61A37-1007-4A16-9D3D-D54BE0224095Q34812959-97EBC189-412D-40CE-A98D-54350158BE93Q34987731-A3E9C661-D9D5-4E6B-8F8F-55A6C2E933D8Q35044376-C498958E-D528-4EFB-89B2-7B7D265A40BDQ35790310-A720D027-F669-4420-834C-7ACB14A62CC9Q35922347-3581A3D2-5722-4C1E-8663-398A229D78D2Q36069114-2C83352F-3149-4067-922D-37CD9262350DQ36114121-7F11458B-B7DE-4BD2-AFE9-F0BF3E3F5CC0Q37198208-568273A2-5B2B-4C3A-978D-146D02347E3EQ37473145-4611A35E-29B2-40A4-A56D-6CAFDEE27F4CQ37616577-0D9808C2-2470-4335-85D9-7EA6F8ED6FEEQ38065295-8B430712-89AC-41D0-A2B4-A952EAC78363Q38182714-D83F57A1-71C0-4459-8972-3A0D3A968BAEQ38218612-CB825B14-4086-48D0-9BC9-6955E4F04A78Q38373388-501D1B22-5C22-47B6-AB6F-260ACC2C1CF5Q40816025-C9D3184D-B853-45C1-A356-71D4983EF645Q41563548-E7EE9735-08D8-42EA-9A87-07CA5A49CCE3Q49644195-71E39EC6-0EEA-4F88-B781-353A1C83CF34Q50725939-CF3B6F12-2016-491C-9A95-EE2F70B747EDQ51434146-9C3CC17F-EA83-47A7-8DAD-B6E5B446EAF2Q51557810-A9E8F846-11C8-42E8-BC88-1C9FDFA8160BQ55385410-26516BC5-A3A5-4C69-B121-359F19642163Q56767722-4852E14D-72B0-473C-9720-F3EB86008034
P2860
Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measuring human papillomavirus ...... n Program Register, Australia.
@en
Measuring human papillomavirus ...... n Program Register, Australia.
@nl
type
label
Measuring human papillomavirus ...... n Program Register, Australia.
@en
Measuring human papillomavirus ...... n Program Register, Australia.
@nl
prefLabel
Measuring human papillomavirus ...... n Program Register, Australia.
@en
Measuring human papillomavirus ...... n Program Register, Australia.
@nl
P356
P1433
P1476
Measuring human papillomavirus ...... n Program Register, Australia.
@en
P2093
Dorota M Gertig
Marion Saville
P304
P356
10.1071/SH10001
P577
2011-06-01T00:00:00Z